top of page

BOTANICAL DRUG CHALLENGES


One of Johns Hopkins University First Female Scientists
Prof. Ru Chih Huang, Ph.D.
  • Botanical drugs are complex

  • Multiple chemical components

  • Not well-defined active component(s)

  • Natural variations

  • Botanical products intended to be marketed as drugs in the United States are expected to meet the same standards as non-botanical drugs for quality, safety, and efficacy.

  • ​ Level of clinical efficacy and safety requirements is the same for botanical and non-botanical drugs



bottom of page